We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+5.39%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$16.1B
AUM Growth
+$1.98B
Cap. Flow
+$1.34B
Cap. Flow %
8.3%
Top 10 Hldgs %
18.52%
Holding
1,899
New
351
Increased
456
Reduced
282
Closed
805

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$260M
2
BABA icon
Alibaba
BABA
+$229M
3
GILD icon
Gilead Sciences
GILD
+$168M
4
BA icon
Boeing
BA
+$151M
5
ABT icon
Abbott
ABT
+$148M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$306M
2
UNH icon
UnitedHealth
UNH
+$244M
3
VMC icon
Vulcan Materials
VMC
+$146M
4
PEP icon
PepsiCo
PEP
+$98.4M
5
ELV icon
Elevance Health
ELV
+$96.5M

Sector Composition

Rank Sector Weight
1 Healthcare 27.6%
2 Technology 15.66%
3 Consumer Discretionary 13.93%
4 Industrials 11.16%
5 Communication Services 8.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CNOB icon
1226
Center Bancorp
CNOB
$1.78B
– –
-5,963
Closed -$118K
CNX icon
1227
CNX Resources
CNX
$5.2B
– –
-72,172
Closed -$777K
COF icon
1228
Capital One
COF
$134B
– –
-70,438
Closed -$5.75M
COTY icon
1229
Coty
COTY
$2.48B
– –
-30,604
Closed -$352K
CPK icon
1230
Chesapeake Utilities
CPK
$3.21B
– –
-4,002
Closed -$365K
CPT icon
1231
Camden Property Trust
CPT
$11.3B
– –
-2,512
Closed -$255K
CRAI icon
1232
CRA International
CRAI
$1.06B
– –
-1,820
Closed -$92K
CRL icon
1233
Charles River Laboratories
CRL
$12.8B
– –
-508
Closed -$74K
CTRA
1234
DELISTED
Coterra Energy
CTRA
– –
-329,671
Closed -$8.6M
CWK icon
1235
Cushman & Wakefield Ltd
CWK
$3.25B
– –
-56,839
Closed -$1.01M
CWST icon
1236
Casella Waste Systems
CWST
$5.69B
– –
-16,182
Closed -$576K
D icon
1237
Dominion Energy
D
$59.3B
– –
-8,300
Closed -$636K
DAN icon
1238
Dana Inc
DAN
$3.06B
– –
-84,740
Closed -$1.5M
DAVA icon
1239
Endava
DAVA
$156M
– –
-5,885
Closed -$162K
DBX icon
1240
Dropbox
DBX
$8.12B
– –
-38,556
Closed -$841K
DCO icon
1241
Ducommun
DCO
$2.98B
– –
-341
Closed -$15K
DELL icon
1242
Dell
DELL
$293B
– –
-99,309
Closed -$2.96M
DESP
1243
DELISTED
Despegar.com
DESP
– –
-7,462
Closed -$112K
DGICB
1244
Donegal Group Class B
DGICB
$891M
– –
-1
Closed –
DLX icon
1245
Deluxe
DLX
$1.15B
– –
-13,474
Closed -$589K
DOC icon
1246
Healthpeak Properties
DOC
$14.8B
– –
-5,800
Closed -$182K
DOX icon
1247
Amdocs
DOX
$6.22B
– –
-70,939
Closed -$3.84M
DRH icon
1248
Diamondrock Hospitality Co
DRH
$2.56B
– –
-3,862
Closed -$42K
DSGX icon
1249
Descartes Systems
DSGX
$6.82B
– –
-3,900
Closed -$142K
DUK icon
1250
Duke Energy
DUK
$97.3B
– –
-16,601
Closed -$1.49M
48 49
50
51 52

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q2 2019 Portfolio in Review

As of Q2 2019, Marshall Wace North America held 1,899 positions worth $16.1B, up 14% from $14.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Marshall Wace North America deployed $1.34B of net new capital in Q2 2019, opening 351 new positions and adding to 456 existing holdings. Its largest new stake was Abbott: 1,884,363 shares worth $158M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 32% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Pfizer, an estimated $306M trimmed.

  • Marshall Wace North America's largest Q2 2019 buy was Abbott: 1,884,363 shares worth $158M.
  • Marshall Wace North America added most to Meta Platforms (Facebook) in Q2 2019, an estimated $260M increase.
  • Marshall Wace North America's biggest Q2 2019 reduction was Pfizer, cutting an estimated $306M.
  • Marshall Wace North America fully exited UnitedHealth in Q2 2019, selling an estimated $244M.
  • Marshall Wace North America's ten largest holdings make up 19% of its $16.1B portfolio in Q2 2019.
  • Marshall Wace North America opened 351 new positions and closed 805 in Q2 2019.
  • Marshall Wace North America's portfolio value rose 14% quarter-over-quarter to $16.1B.

Based on Marshall Wace North America's 13F filing for Q2 2019, filed 14 Aug 2019.